Hyperion Defi (HYPD) Other financing activities (2017 - 2025)
Hyperion Defi (HYPD) posted quarterly Other financing activities of $2.7 million for Q4 2025, up 194.13% year-over-year from $917421.3 in Q4 2024, and up 214.4% quarter-over-quarter from $858270.0 in Q2 2025.
Hyperion Defi (HYPD) Other financing activities (2017 - 2025) Analysis & Trends
Hyperion Defi (HYPD) has reported Other financing activities for 9 consecutive years, with $2.7 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Other financing activities rose 194.13% year-over-year to $2.7 million; the TTM figure through Dec 2025 stood at $4.8 million (up 388349.96% YoY), while the FY2025 annual figure was $3.9 million, up 318172.53% from the prior year.
- Other financing activities advanced to $2.7 million in Q4 2025 per HYPD's latest filing, from $858270.0 in the prior quarter.
- Across five years, Other financing activities topped out at $2.9 million in Q3 2024 and bottomed at -$2.9 million in Q4 2024.
- Historically, Other financing activities has averaged $382599.5 across 5 years, with a median of $1.2 million in 2025.
- Annual changes were most pronounced in 2021 — Other financing activities tumbled 127.49% — and 2025, when it soared 194.13%.
- Hyperion Defi's Other financing activities stood at -$1.9 million in 2021, then advanced by 9.51% to -$1.7 million in 2022, then decreased by 1.09% to -$1.7 million in 2023, then tumbled by 64.88% to -$2.9 million in 2024, then jumped by 194.13% to $2.7 million in 2025.
- Business Quant data shows HYPD's Other financing activities at $2.7 million in Q4 2025, $858270.0 in Q2 2025, and $1.2 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Hyperion Defi | 44.65 Mn | 35.01 Mn | 357,693.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.70 Mn |
| Dec 31, 2025 | 2.70 Mn |
| Jun 30, 2025 | 858,270.00 |
| Jun 30, 2025 | 858,270.00 |
| Mar 31, 2025 | 1.19 Mn |
| Mar 31, 2025 | 1.19 Mn |
| Dec 31, 2024 | -2.87 Mn |
| Dec 31, 2024 | -2.87 Mn |
| Sep 30, 2024 | 2.87 Mn |
| Sep 30, 2024 | 2.87 Mn |
| Dec 31, 2023 | -1.74 Mn |
| Dec 31, 2023 | -1.74 Mn |
| Sep 30, 2023 | 1.74 Mn |
| Sep 30, 2023 | 1.74 Mn |
| Jun 30, 2022 | -1.72 Mn |
| Jun 30, 2022 | -1.72 Mn |
| Mar 31, 2022 | 1.74 Mn |
| Mar 31, 2022 | 1.74 Mn |
| Dec 31, 2021 | -1.90 Mn |
| Dec 31, 2021 | -1.90 Mn |